Cambridge Investment Research Advisors, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.11 - $5.46 $777 - $38,574	-7,065 Reduced 9.57%	66,754 $7,000
Q3 2022 Oct 17, 2022	BUY	$0.17 - $5.31 $68 - $2,124	400 Added 0.54%	73,819 $0
Q2 2022 Jul 13, 2022	SELL	$0.21 - $0.53 $210 - $530	-1,000 Reduced 1.34%	73,419 $18,000
Q1 2022 May 12, 2022	SELL	$0.32 - $0.67 $13,280 - $27,805	-41,500 Reduced 35.8%	74,419 $39,000
Q4 2021 Feb 03, 2022	BUY	$0.6 - $1.11 $15,000 - $27,750	25,000 Added 27.5%	115,919 $71,000
Q3 2021 Nov 02, 2021	BUY	$1.01 - $1.82 $156 - $282	155 Added 0.17%	90,919 $92,000
Q2 2021 Aug 10, 2021	BUY	$1.39 - $2.21 $1,480 - $2,353	1,065 Added 1.19%	90,764 $166,000
Q1 2021 May 07, 2021	SELL	$1.27 - $3.42 $11,874 - $31,977	-9,350 Reduced 9.44%	89,699 $176,000
Q4 2020 Feb 04, 2021	SELL	$0.94 - $1.89 $18,128 - $36,450	-19,286 Reduced 16.3%	99,049 $123,000
Q3 2020 Oct 29, 2020	BUY	$1.5 - $9.38 $78,654 - $491,849	52,436 Added 79.57%	118,335 $213,000
Q2 2020 Jul 27, 2020	BUY	$4.79 - $8.39 $85,357 - $149,509	17,820 Added 37.06%	65,899 $552,000
Q1 2020 May 08, 2020	SELL	$3.44 - $7.21 $2,287 - $4,794	-665 Reduced 1.36%	48,079 $251,000
Q4 2019 Feb 04, 2020	SELL	$4.29 - $5.64 $3,432 - $4,512	-800 Reduced 1.61%	48,744 $266,000
Q3 2019 Nov 06, 2019	BUY	$4.87 - $7.08 $5,113 - $7,434	1,050 Added 2.17%	49,544 $241,000
Q2 2019 Aug 15, 2019	BUY	$6.6 - $7.8 $1,452 - $1,716	220 Added 0.46%	48,494 $0
Q1 2019 May 08, 2019	BUY	$5.76 - $8.95 $4,262 - $6,622	740 Added 1.56%	48,274 $0
Q4 2018 Feb 05, 2019	BUY	$5.26 - $7.97 $61,279 - $92,850	11,650 Added 32.47%	47,534 $277,000
Q3 2018 Nov 02, 2018	BUY	$4.65 - $7.95 $57,567 - $98,421	12,380 Added 52.67%	35,884 $0
Q2 2018 Aug 10, 2018	SELL	$5.05 - $6.8 $62,872 - $84,660	-12,450 Reduced 34.63%	23,504 $0
Q1 2018 May 09, 2018	BUY	$5.6 - $9.25 $50,680 - $83,712	9,050 Added 33.64%	35,954 $0
Q4 2017 Feb 22, 2018	BUY	$6.6 - $7.78 $1,848 - $2,178	280 Added 1.05%	26,904 $0
Q3 2017 Nov 07, 2017	BUY	$5.75 - $7.75 $153,088 - $206,336	26,624	26,624 $190,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$329,249
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$25,890
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$22,588
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account